A detailed history of Prime Capital Investment Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 10,056 shares of BSX stock, worth $909,364. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,056
Previous 8,418 19.46%
Holding current value
$909,364
Previous $648,000 29.94%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$72.96 - $84.0 $119,508 - $137,592
1,638 Added 19.46%
10,056 $842,000
Q2 2024

Aug 08, 2024

SELL
$67.33 - $77.71 $41,071 - $47,403
-610 Reduced 6.76%
8,418 $648,000
Q1 2024

May 14, 2024

SELL
$57.6 - $68.62 $55,065 - $65,600
-956 Reduced 9.58%
9,028 $618,000
Q4 2023

Jan 24, 2024

BUY
$48.64 - $57.81 $485,621 - $577,175
9,984 New
9,984 $577,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.